TearSolutions

TearSolutions is a clinical-stage biotechnology company headquartered in Charlottesville, Virginia focused on developing novel treatments for dry eye disease. The company was the first recipient of the UVA Seed Fund and has a treatment candidate that has advanced into Phase I/II clinical trials.